Comparative Analysis of TA102 and WP2 uvr A( pKM101 ) Strains in Detecting Nitrosamine Mutagens in the Enhanced Ames Test
Environmental and Molecular Mutagenesis · 2025
DOI: 10.1002/em.70018 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Environmental and Molecular Mutagenesis, 2025. Verfasst von Rushikesh M Shukla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, India. Hauptthemen laut MEDLINE: Nitrosamines, Salmonella typhimurium, Mutagens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Zydus Lifesciences Limited.
Abstract (Originalsprache)
The Ames test is a fundamental assay for evaluating chemical mutagenicity, particularly for nitrosamines, which are widespread environmental and pharmaceutical contaminants. To improve sensitivity, regulatory agencies have endorsed the enhanced Ames test (EAT), which incorporates five tester strains, a 30‐min pre‐incubation step, and metabolic activation using both rat and hamster liver S9 fractions. While Salmonella typhimurium TA102 is known for its sensitivity to oxidative mutagens, its performance under EAT conditions has not been fully characterized. This study evaluated the mutagenic response of TA102 using two nitrosamine positive controls: N ‐nitrosodimethylamine (NDMA) and 1‐cyclopentyl‐4‐nitrosopiperazine (CPNP). E. coli WP2 uvr A(pKM101) showed consistent mutagenic responses to both NDMA and CPNP, consistent with existing EAT data. TA102 demonstrated a robust response to NDMA but not to CPNP, suggesting limited sensitivity to certain nitrosamines. These findings support the continued use of WP2 uvr A(pKM101) in EAT protocols and highlight the limited utility of TA102 for comprehensive nitrosamine mutagenicity assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, India.
ORCID-Profile: Rushikesh M Shukla, Darshan T Valani, Chetan K Kajavadara, Satyam N Patel, Laxit K Bhatt, Mukul R Jain
Förderung
- Zydus Lifesciences Limited
Zitieren
APA
Shukla, R. M., Valani, D. T., Kajavadara, C. K., Patel, S. N., Patel, R. J., Bhatt, L. K., Sundar, R., & Jain, M. R. (2025). Comparative Analysis of TA102 and WP2 uvr A( pKM101 ) Strains in Detecting Nitrosamine Mutagens in the Enhanced Ames Test. Environmental and Molecular Mutagenesis. https://doi.org/10.1002/em.70018
Vancouver
Shukla RM, Valani DT, Kajavadara CK, Patel SN, Patel RJ, Bhatt LK, et al. Comparative Analysis of TA102 and WP2 uvr A( pKM101 ) Strains in Detecting Nitrosamine Mutagens in the Enhanced Ames Test. Environmental and Molecular Mutagenesis. 2025. doi:10.1002/em.70018
BibTeX
@article{Shukla2025,
author = {Shukla, Rushikesh M and Valani, Darshan T and Kajavadara, Chetan K and Patel, Satyam N and Patel, Rajesh J and Bhatt, Laxit K and Sundar, Rajesh and Jain, Mukul R},
title = {Comparative Analysis of TA102 and WP2 uvr A( pKM101 ) Strains in Detecting Nitrosamine Mutagens in the Enhanced Ames Test},
journal = {Environmental and Molecular Mutagenesis},
year = {2025},
doi = {10.1002/em.70018}
}
EUVIMED